Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis Children
NCT ID: NCT06947252
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
200 participants
INTERVENTIONAL
2025-01-29
2029-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Intervention on Atopy
NCT06547372
Atopic Dermatitis (AD) and Food Allergy
NCT03168113
Atopy Patch Test in Children With Atopic Dermatitis
NCT02552979
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome was to study frequency of food allergy confirm by oral food challenge among foods avoidance in atopic dermatitis children, focusing on the 6 major food allergens in the Thai children: egg yolk, egg white, cow milk, peanut, wheat and soy. Other outcomes were study type of food reaction after oral food challenge test in atopic dermatitis children (IgE mediated, delayed type: AD flare)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atopic dermatitis children that avoid some foods
Oral food challenge test
Oral food challenge test
Oral food challenge test at home or in the hospital
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral food challenge test
Oral food challenge test at home or in the hospital
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≤ 6 years with diagnosis of atopic dermatitis c
* Now parent report them avoid at least 1 food of egg yolk, egg white, cow milk, peanut, wheat or soy
Exclusion Criteria
* Patients with uncontrolled asthma/ atopic dermatitis
* Patients who had been treated with some other immunotherapy e.g. SCIT, OIT
* Patients with delayed developmental problem or mental disorder
* Patient use beta-blocker, ACEI, ARB
* Patient who unable to follow up
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Punchama Pacharn
Role: PRINCIPAL_INVESTIGATOR
Mahidol University, Siriraj Hospital, Thailand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siriraj Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eapen AA, Kloepfer KM, Leickly FE, Slaven JE, Vitalpur G. Oral food challenge failures among foods restricted because of atopic dermatitis. Ann Allergy Asthma Immunol. 2019 Feb;122(2):193-197. doi: 10.1016/j.anai.2018.10.012. Epub 2018 Oct 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
998/2567(IRB3)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.